Drugs / CD4-zeta gene modified T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01013415 | Sep 2001 → Jun 2005 | HIV infectious disease | University of Pennsylvania | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD4-zeta gene modified T cells | “single infusion of approximately 5 to 11 billion CD4-zeta gene modified T cells” NCT01013415 ↗ |
| Action | Deplete | “find and destroy HIV infected cells” NCT01013415 ↗ |
| Modality | Cell therapy | “gene changed T cells” NCT01013415 ↗ |